Treatment Options for Rosacea
First-line treatment for rosacea should be tailored to the specific phenotype, with topical azelaic acid, ivermectin, or metronidazole recommended for mild to moderate inflammatory lesions, while more severe cases require combination therapy with oral medications. 1
Phenotype-Based Treatment Algorithm
For mild to moderate inflammatory lesions (papulopustular rosacea):
For moderate rosacea requiring more rapid control:
For severe inflammatory lesions:
For persistent erythema:
Newer FDA-Approved Treatment Options
Encapsulated benzoyl peroxide 5% (E-BPO 5%):
Minocycline foam 1.5%:
Maintenance Therapy Considerations
- Long-term maintenance therapy is crucial as up to two-thirds of patients relapse when therapy is discontinued 1
- Topical metronidazole is effective for maintenance therapy and helps prevent relapses 3
- Combination treatment with oral antibiotics at both antimicrobial and subantimicrobial doses is efficacious for treating rosacea 3
General Management Strategies
- Avoid common triggers and use gentle skincare products 2, 1
- Sun protection (SPF 30+), gentle cleansers, and moisturizers are essential adjuncts to pharmacological treatment 1
- Treatment should address the specific signs and symptoms that the patient finds most troubling 2, 1
Common Pitfalls to Avoid
- Poor adherence due to skin irritation can result in up to 89% of patients discontinuing therapy within a month 1
- Overlooking combination therapy for moderate and severe presentations 1
- Not addressing all phenotypic features of rosacea, as multiple cutaneous features may require simultaneous treatment with different agents 1
- Ignoring maintenance therapy, which is essential for preventing relapses 1, 3
Special Considerations
- For ocular rosacea, long-term oral antibiotics and metronidazole gel may be beneficial 4
- Referral to specialists is necessary for patients with ocular complications, severe/recalcitrant rosacea, or phymatous changes 4
- Rhinophyma (swelling and erythema of the nose with dilated pilosebaceous poral orifices) may develop in chronic cases 5